Durable Efficacy of Enfuvirtide Over 48 Weeks in Heavily Treatment-Experienced HIV-1-Infected Patients in the T-20 Versus Optimized Background Regimen Only 1 and 2 Clinical Trials-Reference-Cited by-同舟云学术

Durable Efficacy of Enfuvirtide Over 48 Weeks in Heavily Treatment-Experienced HIV-1-Infected Patients in the T-20 Versus Optimized Background Regimen Only 1 and 2 Clinical Trials

Published:2005-12-01 Issue:4 Volume:40 Page:404-412
ISSN:1525-4135
Container-title:JAIDS Journal of Acquired Immune Deficiency Syndromes
language:en
Short-container-title:

Author:

Nelson Mark,Arastéh Keikawus,Clotet Bonaventura,Cooper David A,Henry Keith,Katlama Christine,Lalezari Jacob P,Lazzarin Adriano,Montaner Julio S. G,O'Hearn Mary,Piliero Peter J,Reynes Jacques,Trottier Benoit,Walmsley Sharon L,Cohen Calvin,Eron Joseph J,Kuritzkes Daniel R,Lange Joep,Stellbrink Hans-Jürgen,Delfraissy Jean-François,Buss Neil E,Donatacci Lucille,Wat Cynthia,Smiley Lynn,Wilkinson Martin,Valentine Adeline,Guimaraes Denise,DeMasi Ralph,Chung Jain,Salgo Miklos P

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Infectious Diseases

Reference18 articles.

1. A synthetic peptide from HIV-1 gp41 is a potent inhibitor of virus-mediated cell-cell fusion.;Wild;AIDS Res Hum Retroviruses,1993

2. Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease.;Murphy;Ann Intern Med,2001

3. Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel.;Yeni;JAMA,2004

4. The prevalence of antiretroviral drug resistance in the United States.;Richman;AIDS,2004

5. Risk of development of drug resistance in patients starting antiretroviral therapy with three or more drugs in routine clinical practice.;Phillips;Antivir Ther,2004

Cited by 137 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence and clinical characteristics of people with HIV with limited treatment options in Japan: A Japanese claims data analysis;Journal of Infection and Chemotherapy;2024-06

2. The evolution of clinical study design in heavily treatment-experienced persons with HIV: A critical review;Antiviral Therapy;2023-05-22

3. A systematic review and meta-analysis assessing antiretroviral therapy for treatment-experienced HIV adult patients using an optimized background therapy approach: is there evidence enough for a standardized third-line strategy?;Systematic Reviews;2022-11-17

4. Enzyme Responsive Delivery of Anti-Retroviral Peptide via Smart Hydrogel;AAPS PharmSciTech;2022-08-24

5. Recent Advances Towards Treatment of HIV: Synthesis and SAR Studies;Mini-Reviews in Medicinal Chemistry;2021-02-16